logo

For the Inventor, By the Inventor

San Marino, CA, United States of America

W French Anderson

This inventor holds 35 USPTO granted patents and 1 published patent application and 6 EPO patents, primarily in Gene Therapy. Top assignees: University of Southern California, California Institute of Technology, The United States of America as Represented by the Department of Health. Active years: 1995-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W French Anderson. Retrieved from https://idiyas.com/inventor/w-french-anderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 

% Patents Active = 65.7


Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 924(Granted Patents)


Location History:

  • Bethesda, MD (US) (1995 - 2007)
  • San Gabriel, CA (US) (2009)
  • Azusa, CA (US) (2011)
  • San Marino, CA (US) (1999 - 2018)
  • Chino, CA (US) (2019 - 2021)

Company Filing History:

goldMedal21 out of 1,695 
 
University of Southern California
 patents
silverMedal7 out of 4,629 
 
California Institute of Technology
 patents
bronzeMedal3 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
4. 2 out of 16 
 
Genetic Therapy, Inc.
 patents
5. 2 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
6. 1 out of 1 
 
The United States of America as Represented by the Secretary Deptartment
 patent
7. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Therapy
Microfluidic Analysis
Hematopoiesis
Nucleic Acid Analysis
Gene Delivery System
Retroviral Vectors
Bone Marrow Preservation
Targeting Pharmaceutical Agents
Modified Viral Proteins
cDNA Libraries
Osteogenic Cell Growth
Vector Particles
35 patents (USPTO):Explore Patents
1. 10940473 - Microfluidic nucleic acid analysis (2021-03-09),
2. 10328428 - Apparatus for preparing cDNA libraries from single cells (2019-06-25),
3. 10029000 - Uses of IL-12 in hematopoiesis (2018-07-24),
4. 9579650 - Microfluidic nucleic acid analysis (2017-02-28),
5. 9402882 - Method for bone marrow preservation or recovery (2016-08-02),
6. 9173922 - Uses of IL-12 in hematopoiesis (2015-11-03),
7. 9023337 - Method for treating deficiency in hematopoiesis (2015-05-05),
8. 8920790 - Uses of IL-12 in hematopoiesis (2014-12-30),
9. 8871446 - Microfluidic nucleic acid analysis (2014-10-28),
10. 8741279 - Gene delivery system and methods of use (2014-06-03),
11. 8652460 - Gene delivery system and method of use (2014-02-18),
12. 8220494 - Microfluidic large scale integration (2012-07-17),
13. 7992587 - Microfluidic autoregulator devices and arrays for operation with newtonian fluids (2011-08-09),
14. 7939058 - Uses of IL-12 in hematopoiesis (2011-05-10),
15. 7611673 - PMDS microfluidic components and methods of operation of the same (2009-11-03),

Title: The Pioneering Work of W French Anderson in Biomedical Innovations

Introduction: W French Anderson, a distinguished inventor hailing from San Marino, CA (US), is renowned for his groundbreaking contributions to the field of biomedical innovations. His work has revolutionized the way we approach genetic research and therapy.

Latest Patents: W French Anderson holds several patents in the field of gene therapy and genetic engineering, focusing on novel techniques to treat genetic disorders and improve patient outcomes.

Career Highlights: With a career spanning several decades, W French Anderson has been at the forefront of genetic research. He is credited with conducting the first successful gene therapy clinical trial in the United States, marking a significant milestone in the field of medicine.

Collaborations: Throughout his career, W French Anderson has collaborated with leading researchers, scientists, and medical professionals to further the advancement of gene therapy. His collaborative efforts have led to innovative solutions for complex genetic conditions.

Conclusion: In conclusion, W French Anderson's pioneering work in biomedical innovations has had a profound impact on the field of genetic research and therapy. His dedication to improving patient care and outcomes continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…